Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 3 2

Status

Completed 9Unknown 6Recruiting 5Withdrawn 1Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 4Gynecologic 2

Conditions

Stomach Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Gynecologic Cancer 1Endometrial Neoplasms 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × OTHER × Enhanced Recovery After Surgery × Clear all
NCT04596800 2023-10-31

PROPER

Instituto Brasileiro de Controle do Cancer

Phase 3 Unknown
194 enrolled
Gynecologic

Gynecologic Cancer

NCT04063072 2021-06-02

ERAS-Gyneco

Ospedale Regina Montis Regalis

Phase NA Unknown
1,800 enrolled
Gynecologic

Uterine Cervical Neoplasms, Uterine Neoplasms, Endometrial Neoplasms

NCT03160924 2020-05-22

The Impact of Enhanced Recovery After Surgery (ERAS) Program on Clinical and Immunological Outcomes for Minimally-invasive Gastrectomy

Chinese University of Hong Kong

Phase 3 Unknown
50 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03121729 2018-04-30

ERASG1

Jinling Hospital, China

Phase NA Unknown
1,000 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03126058 2018-04-30

ERASC1

Jinling Hospital, China

Phase NA Unknown
1,000 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02644603 2017-06-27

Effect of Enhanced Recovery After Surgery(ERAS) After Liver Resection for Primary Liver Cancer

Shanghai Zhongshan Hospital

Phase NA Unknown
214 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡